tiprankstipranks
Advertisement
Advertisement

ELDN Stock Latest News

Natera, Eledon announce strategic partnership
The FlyNatera, Eledon announce strategic partnership
3d ago
ELDN
NTRA
Eledon Pharmaceuticals Expands Authorized Shares After Stockholder Vote
PremiumCompany Announcements
Eledon Pharmaceuticals Expands Authorized Shares After Stockholder Vote
5d ago
8K
ELDN
Eledon Pharmaceuticals announces new long-term data from BESTOW program
PremiumThe Fly
Eledon Pharmaceuticals announces new long-term data from BESTOW program
6d ago
ELDN
Analyst Reiterates Buy on Eledon as Tegoprubart Data Impresses; Price Target Maintained at $6
PremiumRatings
Analyst Reiterates Buy on Eledon as Tegoprubart Data Impresses; Price Target Maintained at $6
20d ago
ELDN
Eledon Pharmaceuticals announces updated results from tegoprubart trial
PremiumThe Fly
Eledon Pharmaceuticals announces updated results from tegoprubart trial
20d ago
ELDN
NewcelX submits NCEL-101 pre-investigational new drug briefing package to FDA
PremiumThe FlyNewcelX submits NCEL-101 pre-investigational new drug briefing package to FDA
1M ago
ELDN
NCEL
Eledon Pharmaceuticals reports Q1 EPS (33c), consensus (23c)
Premium
The Fly
Eledon Pharmaceuticals reports Q1 EPS (33c), consensus (23c)
2M ago
ELDN
Eledon Pharmaceuticals files $500M mixed securities shelf
Premium
The Fly
Eledon Pharmaceuticals files $500M mixed securities shelf
2M ago
ELDN
NewcelX announces release of updated presentation on Type 1 Diabetes program
PremiumThe Fly
NewcelX announces release of updated presentation on Type 1 Diabetes program
2M ago
ELDN
NCEL
Eledon Pharmaceuticals options imply 11.7% move in share price post-earnings
PremiumThe Fly
Eledon Pharmaceuticals options imply 11.7% move in share price post-earnings
3M ago
ELDN
Eledon Pharmaceuticals, Inc. (ELDN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Eledon Pharmaceuticals, Inc. (ELDN) Q4 Earnings Cheat Sheet
3M ago
ELDN
Compelling Tegoprubart Data in Type 1 Diabetes Transplantation Support Buy Rating on Eledon
PremiumRatings
Compelling Tegoprubart Data in Type 1 Diabetes Transplantation Support Buy Rating on Eledon
3M ago
ELDN
Eledon announces updated data from islet transplant trial of tegoprubart
PremiumThe FlyEledon announces updated data from islet transplant trial of tegoprubart
3M ago
ELDN
Eledon Pharmaceuticals announces U.S. FDA granted ODD to tegoprubart
Premium
The Fly
Eledon Pharmaceuticals announces U.S. FDA granted ODD to tegoprubart
4M ago
ELDN
NewcelX announces research agreement with Eledon Pharmaceuticals
Premium
The Fly
NewcelX announces research agreement with Eledon Pharmaceuticals
4M ago
ELDN
NCEL
Eledon Pharmaceuticals: Sustained Tegoprubart Efficacy, Differentiated Safety, and Upcoming Transplant Catalysts Support Buy Rating
PremiumRatings
Eledon Pharmaceuticals: Sustained Tegoprubart Efficacy, Differentiated Safety, and Upcoming Transplant Catalysts Support Buy Rating
5M ago
ELDN
Eledon Pharmaceuticals presents long-term Phase 1b data for tegoprubart
PremiumThe Fly
Eledon Pharmaceuticals presents long-term Phase 1b data for tegoprubart
5M ago
ELDN
Eledon Pharmaceuticals Restructures Stake via Pre-Funded Warrant
PremiumCompany Announcements
Eledon Pharmaceuticals Restructures Stake via Pre-Funded Warrant
6M ago
8K
ELDN
Eledon Pharmaceuticals Reports Q3 2025 Financial Results
PremiumCompany Announcements
Eledon Pharmaceuticals Reports Q3 2025 Financial Results
7M ago
ELDN
Eledon Pharmaceuticals reports preliminary tegoprubart trial results
PremiumThe FlyEledon Pharmaceuticals reports preliminary tegoprubart trial results
7M ago
ELDN
Eledon Pharmaceuticals price target lowered to $8 from $9 at Guggenheim
Premium
The Fly
Eledon Pharmaceuticals price target lowered to $8 from $9 at Guggenheim
7M ago
ELDN
Eledon Pharmaceuticals: Promising Kidney Transplant Program and Strong Financial Position Support Buy Rating
Premium
Ratings
Eledon Pharmaceuticals: Promising Kidney Transplant Program and Strong Financial Position Support Buy Rating
7M ago
ELDN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >